What is a stock summary page? Click here for an overview.
Business Description
Lotus Eye Hospital & Institute Ltd
ISIN : INE947I01017
Compare
Compare
Traded in other countries / regions
532998.India IPO Date
2008-07-11Description
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.52 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.54 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 9.96 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.3 | |||||
| 3-Year EBITDA Growth Rate | 21.4 | |||||
| 3-Year EPS without NRI Growth Rate | 24.8 | |||||
| 3-Year FCF Growth Rate | -74 | |||||
| 3-Year Book Growth Rate | 4.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 91.65 | |||||
| 9-Day RSI | 80.67 | |||||
| 14-Day RSI | 72.24 | |||||
| 3-1 Month Momentum % | 7.2 | |||||
| 6-1 Month Momentum % | 7.82 | |||||
| 12-1 Month Momentum % | 18.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.52 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.59 | |||||
| Days Inventory | 49.84 | |||||
| Days Sales Outstanding | 10.32 | |||||
| Days Payable | 59.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.98 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.06 | |||||
| Operating Margin % | -0.52 | |||||
| Net Margin % | 1.07 | |||||
| FCF Margin % | 0.08 | |||||
| ROE % | 0.86 | |||||
| ROA % | 0.75 | |||||
| ROIC % | -0.41 | |||||
| 3-Year ROIIC % | 14.15 | |||||
| ROC (Joel Greenblatt) % | 1.67 | |||||
| ROCE % | 1.38 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 292.84 | |||||
| PE Ratio without NRI | 294.02 | |||||
| Shiller PE Ratio | 87.81 | |||||
| Price-to-Owner-Earnings | 39.19 | |||||
| PEG Ratio | 14.48 | |||||
| PS Ratio | 3.2 | |||||
| PB Ratio | 2.53 | |||||
| Price-to-Tangible-Book | 2.54 | |||||
| Price-to-Free-Cash-Flow | 3853.16 | |||||
| Price-to-Operating-Cash-Flow | 26.79 | |||||
| EV-to-EBIT | 179.81 | |||||
| EV-to-EBITDA | 27.15 | |||||
| EV-to-Revenue | 3.14 | |||||
| EV-to-FCF | 3739.33 | |||||
| Price-to-GF-Value | 1.01 | |||||
| Price-to-Projected-FCF | 2.58 | |||||
| Price-to-DCF (Earnings Based) | 11.45 | |||||
| Price-to-DCF (FCF Based) | 390.37 | |||||
| Price-to-Median-PS-Value | 1.65 | |||||
| Price-to-Peter-Lynch-Fair-Value | 11.75 | |||||
| Price-to-Graham-Number | 3.48 | |||||
| Price-to-Net-Current-Asset-Value | 84.28 | |||||
| Earnings Yield (Greenblatt) % | 0.56 | |||||
| FCF Yield % | 0.03 | |||||
| Forward Rate of Return (Yacktman) % | 20 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lotus Eye Hospital & Institute Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 479.64 | ||
| EPS (TTM) (₹) | 0.25 | ||
| Beta | 1.71 | ||
| 3-Year Sharpe Ratio | 0.24 | ||
| 3-Year Sortino Ratio | 0.41 | ||
| Volatility % | 44.15 | ||
| 14-Day RSI | 72.24 | ||
| 14-Day ATR (₹) | 3.742277 | ||
| 20-Day SMA (₹) | 66.8905 | ||
| 12-1 Month Momentum % | 18.51 | ||
| 52-Week Range (₹) | 52.35 - 90.98 | ||
| Shares Outstanding (Mil) | 20.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lotus Eye Hospital & Institute Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lotus Eye Hospital & Institute Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lotus Eye Hospital & Institute Ltd Frequently Asked Questions
What is Lotus Eye Hospital & Institute Ltd(NSE:LOTUSEYE)'s stock price today?
The current price of NSE:LOTUSEYE is ₹74.17. The 52 week high of NSE:LOTUSEYE is ₹90.98 and 52 week low is ₹52.35.
When is next earnings date of Lotus Eye Hospital & Institute Ltd(NSE:LOTUSEYE)?
The next earnings date of Lotus Eye Hospital & Institute Ltd(NSE:LOTUSEYE) is .
Does Lotus Eye Hospital & Institute Ltd(NSE:LOTUSEYE) pay dividends? If so, how much?
Lotus Eye Hospital & Institute Ltd(NSE:LOTUSEYE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers